Ardi Pambuku

Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial

Giuseppe Lombardi, Gian Luca De Salvo, Alba A. Brandes et al. · The Lancet Oncology · 2018 · 386 citations

Medicine, Oncology, Pharmacology +13

Genetic, Epigenetic, and Immunologic Profiling of MMR-Deficient Relapsed Glioblastoma

Stefano Indraccolo, Giuseppe Lombardi, Matteo Fassan et al. · Clinical Cancer Research · 2018 · 104 citations

Medicine, Molecular Biology, Oncology +17

Diagnostic Value of Plasma and Urinary 2-Hydroxyglutarate to Identify Patients With Isocitrate Dehydrogenase-Mutated Glioma

Giuseppe Lombardi, Giuseppe Corona, Luisa Bellu et al. · The Oncologist · 2015 · 64 citations · Full text

Medicine, Biochemistry, Oncology +17

Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology)

Giuseppe Lombardi, Andrea Pace, Francesco Pasqualetti et al. · Journal of Neuro-Oncology · 2015 · 44 citations

Medicine, Oncology, Radiation Oncology +17

Quality of Life Perception, Cognitive Function, and Psychological Status in a Real-world Population of Glioblastoma Patients Treated With Radiotherapy and Temozolomide

Giuseppe Lombardi, Eleonora Bergo, Paola Del Bianco et al. · American Journal of Clinical Oncology · 2018 · 26 citations

Medicine, Oncology, Radiation Oncology +15